Preschool Attention and Sleep Support (PASS)

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05862727
Collaborator
National Institute of Mental Health (NIMH) (NIH)
44
1
2
21
2.1

Study Details

Study Description

Brief Summary

This study will be investigating two telehealth interventions for preschoolers with ADHD. The study is divided into two Aims. During Aim 1, caregivers of preschoolers with attention concerns, pediatric behavioral health professionals, and pediatric primary care providers will take part in two virtual focus groups to provide their perspective on ways to improve the telehealth intervention being evaluated.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telehealth Intervention
N/A

Detailed Description

During Aim 2, caregivers of preschool children with ADHD symptoms will be randomly assigned to participate in one of two 8-week telehealth interventions. Both interventions will teach evidence-based skills and provide practice opportunities to manage their children's ADHD-related behaviors. Caregivers and their children will also attend three study visits (one before the intervention, and two following the intervention) where they will be asked to complete questionnaires and assessments related to the child's ADHD symptoms, psychiatric health, and sleep habits. Following each study visit, participating children will be asked to wear an ActiGraph device on their nondominant wrist for 24 hours/day for a 7-day period. During this time, the caregivers will be asked to complete an electronic daily diary about their child's sleep.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Behavioral Telehealth InterventionBehavioral Telehealth Intervention
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participants will be randomly assigned to one of two interventions, and will not be told which intervention they are assigned to. Outcomes assessor will also be blinded to intervention assignment.
Primary Purpose:
Treatment
Official Title:
Preschool Attention and Sleep Support (PASS): A Telehealth Intervention for Children at Risk for ADHD
Anticipated Study Start Date :
Aug 10, 2023
Anticipated Primary Completion Date :
May 10, 2025
Anticipated Study Completion Date :
May 10, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: PASS Arm1

Caregivers will receive sessions of evidence-based behavioral parent training which focuses on improving behaviors, such as establishing daytime and bedtime routines, through enhancement of positive parenting skills, including modifying antecedents, applying/withdrawing positive attention as a consequence, and shaping behavior using salient rewards.

Behavioral: Telehealth Intervention
Telehealth intervention that teaches caregivers evidence-based skills and provides practice opportunities to manage their children's ADHD-related behaviors according to their assigned intervention.

Active Comparator: PASS Arm2

Caregivers will receive sessions of evidence-based behavioral parent training which focuses on improving behaviors, including in home and public settings, through enhancement of positive parenting skills, including modifying antecedents, applying/withdrawing positive attention as a consequence, and shaping behavior using salient rewards.

Behavioral: Telehealth Intervention
Telehealth intervention that teaches caregivers evidence-based skills and provides practice opportunities to manage their children's ADHD-related behaviors according to their assigned intervention.

Outcome Measures

Primary Outcome Measures

  1. Change in clinician-rated ADHD-RS [Baseline, immediately post-treatment, 3 months post-treatment]

    A clinician-rated, 18-item assessment with a 4-point Likert scale ranging from Rarely or never to Very Often. Lower scores indicate better outcomes.

  2. Change in caregiver-reported sleep habits as measured by the Short-Form Child Sleep Habits Questionnaire (SF-CSHQ). [Baseline, immediately post-treatment, 3 months post-treatment]

    A 23-item questionnaire with a 3-point Likert scale ranging from Rarely to Usually. Lower scores indicate better outcomes.

  3. Change in Sleep Regularity Index (SRI) [Baseline, immediately post-treatment, 3 months post-treatment]

    A measure of sleep regularity collected continuously over 7 days via Actigraphy. The SRI is calculated as the proportion of pairs of time points 24 hours apart that have matching sleep/wake status

Secondary Outcome Measures

  1. Change in psychosocial function as measured by Impairment Rating Scale [Baseline, immediately post-treatment, 3 months post-treatment]

    A clinician rated, 8-item assessment with a 7-point Likert scale ranging from No problem; definitely does not need treatment/special services to Extreme Problem; definitely needs treatment/special services. Lower scores indicate better outcomes.

  2. Change in parenting stress as measured by the Parenting Stress Scale [Baseline, immediately post-treatment, 3 months post-treatment]

    An 18-item questionnaire with a 5-point Likert Scale ranging from Strongly disagree to Strongly Agree. Lower scores indicate better outcomes.

  3. Change in comorbid symptoms as measured by Child Behavioral Checklist for Ages 1½ to 5(CBCL) [Baseline, immediately post-treatment, 3 months post-treatment]

    A widely-used 99-item parent report questionnaire with a 3-point Likert Scale ranging from Not True to Very True or Often True. Lower scores indicate better outcomes.

  4. Change in sleep midpoint, TST (minutes from sleep start to sleep end), SOL (minutes to first sleep epoch), WASO (minutes awake between sleep start and sleep end), and SE (TST/time in bed). [Baseline, immediately post-treatment, 3 months post-treatment]

    As measured via actigraphy collected continuously over 7 days.

  5. Change in parenting style as measured by the Alabama Parenting Questionnaire [Baseline, immediately post-treatment, 3 months post-treatment]

    A 33-item questionnaire with a 5-point Likert Scale ranging from Never to Always.

  6. Change in severity of behavior problems in the home setting as measured by the Home Situations Questionnaires. [Baseline, immediately post-treatment, 3 months post-treatment]

    A 16-item questionnaire with a 9-point Likert Scale. Lower scores indicate better outcomes.

Other Outcome Measures

  1. Treatment Fidelity [During the 8-week treatment]

    The percentage of content and practices of the PASS protocol that were delivered (yes/no) across providers as determined by rater's assessment of recorded sessions.

  2. Feasibility of Recruitment [Baseline]

    The percentage of enrolled participants who attend a screening visit.

  3. Feasibility of Randomization [Baseline]

    The percent of randomized participants who meet study eligibility after attending the screening visit.

  4. Integrity of the control condition as measured by the PASS Fidelity Checklist. [During the 8-week treatment]

    The incidence of administration of core PASS elements in each session of the control group determined by rater.

  5. Integrity of the control condition as measured by the Integrity of the Blind questionnaire. [immediately post-treatment]

    Asking all blinded informant (parents, assessors) to guess whether the child was in the control or experimental group and to state their confidence in this guess on a 1 to 10 scale. Higher scores indicate higher confidence in guess.

  6. Index of treatment engagement as measured by attendance. [During the 8-week treatment]

    Average number PASS groups sessions attended by participants.

  7. Adherence to between-session practice. [During the 8-week treatment]

    Assessed via a therapist-completed item assessing the degree to which the caregiver was adherent overall with homework immediately after each session on a scale of 1 (not at all) to 5 (extremely strong).

  8. Retention [Immediately post-treatment, 3 months post-treatment]

    Measured by the number of families who complete post-treatment and follow-up assessments.

  9. Acceptability as measured by the Satisfaction with Therapy and Therapist Scale (STTS-R). [Immediately post-treatment]

    A 13-item questionnaire with a 5-point Likert Scale ranging from Strongly Disagree (1) to Strongly Agree (5). Higher scores indicate better outcomes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • child must be ages 3-5 years at intake

  • child with score of 30 on the Child Sleep Habits Survey-Short Form and a caregiver rating of child's sleep problems as moderate/severe

  • child with ≥80th percentile on the clinician-rated ADHD-RS based on age and sex norms, with at least 4 symptoms in the clinically significant range (scores of 2-3) in either the inattention or hyperactive/impulsive domains

  • parent/caregiver must have ability to speak, read, and write in English

  • parent/caregiver must have access to a device with internet and/or smartphone to access telehealth visits

  • parent/caregiver must have ability to follow written and verbal instructions

  • parent/caregiver must have ability and willingness to comply with study procedures.

Exclusion Criteria:
  • child with suspected obstructive sleep apnea or restless legs syndrome (via screening questionnaires)

  • child with current use of stimulant medication, other psychotropics, or medications for sleep (prescription or over-the-counter, including melatonin)

  • child with caregiver report of psychiatric disorder other than ADHD requiring treatment (medication and/or therapy), Autism Spectrum Disorder, or intellectual disability

  • parent/caregiver are not currently participating in another parent training intervention and have not previously participated in another parent training intervention in the past 6 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27705

Sponsors and Collaborators

  • Duke University
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Jessica Lunsford-Avery, PhD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05862727
Other Study ID Numbers:
  • Pro00111845
  • R34MH131994-01
First Posted:
May 17, 2023
Last Update Posted:
May 17, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University

Study Results

No Results Posted as of May 17, 2023